Biliary AtresiaGeneticsRare diseaseChildren's health
What this study is
This project will primarily evaluate the developmental/genetic basis of biliary atresia, the most common cause of liver failure at birth, and which accounts of half of all liver transplants performed worldwide in children.
Study details
- Official title
- Coordinating Center- Mapping Disease Pathways for Biliary Atresia
- Sponsor
- University of Pittsburgh
- Conditions
- Biliary Atresia
- Enrolling
- 1,100 people
- Starts
- 2016-07-21
- Est. completion
- 2035-07-21
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers Not acceptedYou may qualify if
- Living individuals who were diagnosed with Biliary Atresia and received or are about to receive a liver transplant from multiple participating centers (Children's Hospital of Pittsburgh, Kings College Hospital, Children's Hospital of Birmingham, and Hospital Sírio-Libanês).
You can't join if
- No child participant in the care of the state will be enrolled, nor will patients in the care of temporary or informal guardians be enrolled
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openUPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Morgan L Paul, BSN · Contact412-692-8472Morgan.Paul2@upmc.edu
- Daniel Pieratt, MPA · Contact4126926692pierattdw@upmc.edu
- Rakesh Sindhi, MD · Principal investigator
Recruiting
Study team
Sponsor
University of Pittsburgh
Study ID STUDY19070273
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.